SCHEMBL1824468

SCHEMBL1824468

NCCC(=O)OCc1ccc(OS(=O)(=O)c2ccccc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.48
LMNA P02545 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.43
MAPT P10636 2/20 0.43
ALDH1A1 P00352 2/20 0.43
MAPK1 P28482 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
ENPP3 O14638 6/20 0.42
ENPP1 P22413 6/20 0.42
ENPP2 Q13822 4/20 0.42
CA2 P00918 3/20 0.42
CA9 Q16790 1/20 0.42
CA1 P00915 2/20 0.41
PKM P14618 1/20 0.41
F2 P00734 1/20 0.41
MEN1 O00255 1/20 0.40
POLB P06746 1/20 0.40
KMT2A Q03164 1/20 0.40
P2RX7 Q99572 1/20 0.40
CDC25B P30305 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1823171 0.90 TDP1 (0.49) TDP1LMNASMN1; SMN2MAPTALDH1A1
SCHEMBL1827217 0.85 ALDH1A1 (0.51) TDP1LMNASMN1; SMN2MAPTALDH1A1
SCHEMBL1826815 0.82 TDP1 (0.46) TDP1LMNASMN1; SMN2MAPTALDH1A1
SCHEMBL1827283 0.82 ALDH1A1 (0.54) TDP1LMNASMN1; SMN2MAPTALDH1A1
SCHEMBL1824230 0.82 ADAMTS4 (0.46) TDP1LMNASMN1; SMN2ALDH1A1MAPK1
SCHEMBL13248936 0.79 ALDH1A1 (0.66) TDP1LMNAMAPTALDH1A1MAPK1
SCHEMBL958928 0.79 ALDH1A1 (0.66) TDP1LMNAMAPTALDH1A1MAPK1
SCHEMBL27341665 0.78 TDP1 (0.61) TDP1SMN1; SMN2MAPTALDH1A1ENPP3
Hydrochloric Acid SCHEMBL7367924 0.77 ALDH1A1 (0.63) TDP1LMNAMAPTALDH1A1MAPK1
SCHEMBL1821229 0.76 TDP1 (0.46) TDP1SMN1; SMN2MAPTALDH1A1ENPP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161254-B1 Intermediate for preparing a biaryl compound SUMITOMO CHEMICAL CO (JP) 2014-08-13 EP disclosed
EP-1481967-B1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2011-05-04 EP disclosed
US-7714157-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-05-11 US disclosed
EP-2161254-A1 Intermediate for preparing a biaryl compound Sumitomo Chemical Company, Limited (JP) 2010-03-10 EP disclosed
US-20070270603-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2007-11-22 US disclosed
US-7271280-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-18 US disclosed
EP-1481967-A1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS Sumitomo Chemical Company, Limited (JP) 2004-12-01 EP disclosed
US-20040158093-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040158093-A1 Process for preparing a biaryl compound CYP1B1, REL, CYP2F1 TDP1 4543/4885LMNA 1802/4885SMN1; SMN2 2274/4885
US-20070270603-A1 Process for preparing a biaryl compound CYP4A11, CYP4B1, CYP51A1 TDP1 4702/4885LMNA 1130/4885SMN1; SMN2 3216/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.